PSMD10 and hepatocellular carcinoma: Gankyrin expression levels have been positively associated with metastatic potential and are negatively associated with patient overall survival in hepatocellular carcinoma, esophageal squamous cell carcinoma, gastric cancer and colorectal cancer [19, 24, 25, 41].